Clínica Mayo de U.M.C.B. S.R.L

San Miguel de Tucumán, Tucumán Province T4000IHE

1 studies enrolling now · 6 studies all time

What they study most

Diffuse Cutaneous Systemic Sclerosis, SARS-CoV-2 Infection, Sclerosis, Systemic, Sjogren Disease, Sjogren's Syndrome, Sjögren's Syndrome, Sjögren's Syndrome (SS)

Studies at this site

• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
• A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
• A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
• An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) — Stopped early
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed